Jan 29 (Reuters) - Shanghai Henlius Biotech Inc 2696.HK :
* APPLICATION FOR CLINICAL TRIAL OF HLX04-O INJECTION APPROVED BY TGA
* PHASE 3 CLINICAL TRIAL FOR HLX04-O PERMITTED TO COMMENCE IN AUSTRALIA
Jan 29 (Reuters) - Shanghai Henlius Biotech Inc 2696.HK :
* APPLICATION FOR CLINICAL TRIAL OF HLX04-O INJECTION APPROVED BY TGA
* PHASE 3 CLINICAL TRIAL FOR HLX04-O PERMITTED TO COMMENCE IN AUSTRALIA